American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219,727 | 144,473 | 159,031 | 166,410 | 170,624 |
| Receivables | 24,556 | 17,332 | 14,348 | 16,495 | 15,424 |
| Inventories | 17,251 | 18,969 | 20,021 | 12,265 | 15,350 |
| Income taxes - deferred | 530 | N/A | N/A | N/A | N/A |
| Other current assets | 9,059 | 10,579 | 27,329 | 11,703 | 9,514 |
| TOTAL | $271,123 | $191,354 | $220,729 | $206,872 | $210,911 |
| Non-Current Assets | |||||
| PPE Net | 70,082 | 50,562 | 49,889 | 48,497 | 42,596 |
| Investments And Advances | 21,480 | 19,319 | 250 | 243 | 191 |
| Intangibles | 111,418 | 97,532 | 97,363 | 95,849 | 61,984 |
| Other Non-Current Assets | 29,358 | 37,009 | 1,736 | 2,254 | 1,601 |
| TOTAL | $232,338 | $204,422 | $149,237 | $146,843 | $106,371 |
| Total Assets | $503,907 | $396,552 | $370,701 | $353,715 | $317,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,966 | 2,958 | 2,896 | 2,375 | 978 |
| Accounts payable and accrued liabilities | 17,468 | 12,954 | 9,409 | 11,223 | 12,225 |
| Other current liabilities | 2,263 | 2,712 | 2,941 | 3,549 | 13,845 |
| TOTAL | $34,573 | $29,443 | $24,233 | $26,461 | $35,481 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,115 | 1,126 | 1,133 | 1,550 | 2,876 |
| Other Non-Current Liabilities | 115,000 | 0 | 0 | 0 | 2 |
| TOTAL | $132,506 | $17,839 | $16,613 | $14,171 | $11,761 |
| Total Liabilities | $167,079 | $47,282 | $40,846 | $40,632 | $47,241 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78 | 78 | 78 | 78 | 75 |
| Common Shares | 358 | 261 | 359 | 78 | 75 |
| Retained earnings | 141,883 | 125,400 | 111,540 | 102,118 | 86,853 |
| Other shareholders' equity | -913 | 28,356 | 23,201 | 17,878 | 10,321 |
| TOTAL | $336,829 | $349,270 | $329,855 | $313,083 | $270,214 |
| Total Liabilities And Equity | $503,908 | $396,552 | $370,701 | $353,715 | $317,455 |